Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women undergoing controlled ovarian stimulation

X
Trial Profile

A randomised, assessor-blind, active-controlled, parallel-group, dose-finding trial to investigate the efficacy and safety of FE 999302 for triggering of final follicular maturation in women undergoing controlled ovarian stimulation

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 22 May 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chorionic gonadotropin (Primary) ; Choriogonadotropin alfa
  • Indications Infertility
  • Focus Therapeutic Use
  • Acronyms TIFFANY
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 22 May 2023 This trial has been discontinued in Spain, according to European Clinical Trials Database record.
    • 21 Jan 2023 This trial has been discontinued in Czech Republic (End Date: 13 Dec 2022) according to European Clinical Trials Database record.
    • 05 Jan 2023 Status changed from suspended to withdrawn prior to enrolment. Based on company decision to close the project. No trial participants received any study drug.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top